FPS
ALXN

Fieldpoint Private Securities’s Alexion Pharmaceuticals ALXN Stock Holding History

Fieldpoint Private Securities’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-105
Closed -$16K – 1672
2021
Q1 		$16K Hold
105
– – ﹤0.01% 865
2020
Q4 		$16K Buy
+105
New +$13.5K ﹤0.01% 766
2020
Q1 		– Sell
-1,096
Closed -$119K – 621
2019
Q4 		$119K Sell
1,096
-198
-15% -$21.2K 0.04% 321
2019
Q3 		$127K Sell
1,294
-70
-5% -$7.89K 0.05% 255
2019
Q2 		$179K Hold
1,364
– – 0.06% 244
2019
Q1 		$184K Buy
1,364
+88
+7% +$10.9K 0.08% 201
2018
Q4 		$124K Sell
1,276
-1,180
-48% -$139K 0.06% 224
2018
Q3 		$341K Hold
2,456
– – 0.13% 160
2018
Q2 		$305K Buy
2,456
+70
+3% +$8.18K 0.12% 169
2018
Q1 		$266K Hold
2,386
– – 0.12% 147
2017
Q4 		$285K Buy
2,386
+594
+33% +$72.3K 0.15% 138
2017
Q3 		$251K Buy
1,792
+1,122
+167% +$152K 0.11% 172
2017
Q2 		$82K Buy
+670
New +$78K 0.09% 100

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $7.94B AUM 55.6% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.37B AUM 63.08% 1-Year Est. Return